Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate in atherosclerosis
NCT00760019Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Amigesic in atherosclerosis, sponsored by Brigham and Women's Hospital. Started Aug 2005; status: completed.
02
Drugs
Amigesic
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00760019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760019.